Margot Brickelmaier

Structural and Functional Differences Between Glycosylated and Non-glycosylated Forms of Human Interferon-β (IFN-β)

Laura Runkel, Werner Meier, R. Blake Pepinsky et al. · Pharmaceutical Research · 1998 · 300 citations

Identification and Characterization of Mefloquine Efficacy against JC Virus In Vitro

Margot Brickelmaier, Alexey A. Lugovskoy, Ramya Kartikeyan et al. · Antimicrobial Agents and Chemotherapy · 2009 · 237 citations · Full text

Viral Pathogenesis, Immunology, Pathology +19

Progressive Multifocal Leukoencephalopathy (PML) Development Is Associated With Mutations in JC Virus Capsid Protein VP1 That Change Its Receptor Specificity

Leonid Gorelik, Carl E. Reid, Manuela Testa et al. · The Journal of Infectious Diseases · 2011 · 157 citations · Full text

Molecular Virology, Receptor Specificity, Medicine +13

N-Terminally PEGylated Human Interferon-β-1a with Improved Pharmacokinetic Properties and in Vivo Efficacy in a Melanoma Angiogenesis Model

Darren P. Baker, Edward Yin-Shiang Lin, Ko‐Chung Lin et al. · Bioconjugate Chemistry · 2005 · 144 citations

Alefacept, an Immunomodulatory Recombinant LFA-3/IgG1 Fusion Protein, Induces CD16 Signaling and CD2/CD16-Dependent Apoptosis of CD2+ Cells

Antonio J. da Silva, Margot Brickelmaier, Gerard R. Majeau et al. · The Journal of Immunology · 2002 · 133 citations · Full text